January 16, 2018 8:32 PM ET

Company Overview of Université de Lausanne

Company Overview

University of Lausanne is an educational institution.

University of Lausanne

Lausanne,  CH-1015

Switzerland

Founded in 1890

Phone:

41 21 692 11 11

Fax:

41 21 692 26 15

Key Executives for Université de Lausanne

Université de Lausanne does not have any Key Executives recorded.

Université de Lausanne Key Developments

Université de Lausanne Presents at American Society of Human Genetics Annual Meeting, Oct-21-2017 09:45 AM

Université de Lausanne Presents at American Society of Human Genetics Annual Meeting, Oct-21-2017 09:45 AM. Venue: Orlando, Florida, United States. Speakers: Alexandre Reymond.

Université de Lausanne Presents at Spring Conference 2017 Frontiers in Central Banking, Jun-13-2017 02:00 PM

Université de Lausanne Presents at Spring Conference 2017 Frontiers in Central Banking, Jun-13-2017 02:00 PM. Venue: Wilhelm-Epstein-Straße 14, 60431, Frankfurt am Main, Germany. Speakers: Philippe Bacchetta.

Medigene AG Announces Collaboration Agreement with University of Lausanne

Medigene AG announced a collaboration agreement with the University of Lausanne in order to establish a better and faster method for selecting tumour-specific T cells characterised by expression of suitable T cell receptors (TCRs) for Medigene's expanding TCR library. The agreement provides Medigene access to the NTAmer technology that has been established by TCMetrix, a spin-off company of the Ludwig Institute for Cancer Research in Lausanne, and further developed in collaboration with leading scientists of the University of Lausanne. Financial terms of the agreement were not disclosed. Within the framework of the cooperation, scientists of the Department of Oncology of the University of Lausanne will perform kinetic dissociation analyses on human T cells using the innovative NTAmer technology. This technology measures cell-surface monomeric TCR-peptide-MHC dissociation rates of TCR candidates, which will allow Medigene to select tumour-specific T cells with an optimal functional avidity for different cancer cell types. The tailor-made NTAmer reagents are patented and will be provided by TCMetrix Ltd.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Université de Lausanne, please visit www.unil.ch. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.